Research

  • Mapping tool targets nutrition access for healthy ageing

    A new government-backed project is using mapping technology to guide mobile greengrocers to areas where residents struggle to access fresh, healthy food essential for ageing well. Announced on 7 July, the initiative is part of a wider programme in which six projects across the UK will share £8.5m in funding to tackle food inequality and [...]

  • Brain sugar stores linked to Alzheimer’s development

    Glucose stored in the brain may play a more active role in driving neuron damage than previously believed, raising new possibilities for treating Alzheimer's disease. The research challenges the long-held view that glycogen – the storage form of glucose – is simply a backup energy supply for the liver and muscles. Instead, scientists have identified [...]

  • Childhood health linked to men’s disease risk

    Being overweight in childhood or having chickenpox or another infectious disease in infancy may raise the risk of chronic illness in adult men, new research suggests. Scientists found that these early-life health factors can lower levels of a key reproductive hormone by 10 to 15 per cent in young men, potentially increasing their risk of [...]

  • Air pollution linked to lung cancer in non-smokers

    Air pollution and exposure to certain herbal medicines have been linked to genetic mutations that may drive lung cancer in people who have never smoked. While lung cancer has long been associated with smoking, global declines in tobacco use have coincided with a growing proportion of cases in never-smokers. This trend appears to affect women [...]

  • Statins could help prevent thousands of heart attacks

    Tens of thousands of Americans are suffering avoidable heart attacks and strokes each year because they are not being prescribed cholesterol-lowering drugs they qualify for. More than 39,000 deaths, nearly 100,000 non-fatal heart attacks and up to 65,000 strokes in the US could be avoided annually if all eligible people were taking statins and other [...]

  • 3D-printed implants offer new hope for type 1 diabetes

    Scientists have created 3D-printed devices containing insulin-producing cells that could offer long-term treatment for type 1 diabetes without the need for invasive surgery. The small implants, designed to be placed just under the skin, would allow people with type 1 diabetes to produce their own insulin, potentially reducing the need for daily injections and constant [...]

  • Ozempic-style drug shows promise for type 1 diabetes

    Semaglutide, the active ingredient in Ozempic, has shown potential to improve blood sugar control in people with type 1 diabetes, a clinical trial has found. The drug, already used to treat type 2 diabetes and support weight loss, may offer a new treatment option for type 1, used alongside insulin. Researchers at Indiana University, led [...]

  • Round up: US$12m to accelerate research in longevity, new partnership to accelerate Alzheimer’s drug discovery, and more

    Age Tech World explores the latest developments in business in the world of ageing and longevity. US$12m to accelerate research in longevity Longevity startup Circulate Health has announced that it raised US$12m in seed funding. The company’s patented method of therapeutic plasma exchange uses a procedure that separates, removes, and replaces a patient's plasma to [...]

  • Heart ageing may be reversed by altering cell environment

    Altering the environment around heart cells could help reverse age-related cardiac decline, a new study suggests. Instead of focusing on heart cells themselves, the researchers examined the extracellular matrix (ECM) – the protein- and molecule-based structure that surrounds and supports these cells. This matrix, which acts like scaffolding, helps maintain tissue integrity and relays biochemical [...]

  • Common medications linked to higher dementia risk

    Taking certain widely prescribed medications over several years may increase the risk of dementia by nearly 50 per cent, researchers have found. The study identified a significantly higher dementia risk in people aged 55 and over who took strong anticholinergic drugs daily for three years or more. Anticholinergic drugs block acetylcholine, a chemical messenger involved [...]